Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology

NCT03012139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2020-01-21

No results posted yet for this study

Summary

This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Rajiv Kumar, MD · Mayo Clinic

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-10-11
Completion
2019-10-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03012139 on ClinicalTrials.gov